Clinical trials
Osteoarthritis trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Recruiting | 7 |
| Unknown status | 7 |
| Active, not recruiting | 6 |
| Terminated | 6 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zimmer Biomet | 9 |
| DePuy Orthopaedics | 4 |
| Maastricht University Medical Center | 3 |
| Reinier Haga Orthopedisch Centrum | 3 |
| AstraZeneca | 2 |
| Cotera, Inc. | 2 |
| Erasmus Medical Center | 2 |
| Grünenthal GmbH | 2 |
| Isala | 2 |
| Biomet Nederland BV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Osteoarthritis | 63 |
| Arthritis, Rheumatoid | 11 |
| Arthritis | 8 |
| Osteoarthritis, Knee | 8 |
| Pain | 5 |
| Osteoarthritis, Hip | 3 |
| Osteonecrosis | 3 |
| Spondylitis, Ankylosing | 2 |
| Ankylosis | 1 |
| Bone Diseases, Metabolic | 1 |
Trials
Showing 51 to 63 of 63. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.